comparemela.com

Latest Breaking News On - ஸ்டீவன் லிட்ச்மேன் - Page 1 : comparemela.com

The Cooper Companies (COO) Q2 2021 Earnings Call Transcript

The Cooper Companies (COO) Q2 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. The Cooper Companies (NYSE: COO) Q2 2021 Earnings Call Hello, and thank you for standing by. Welcome to the second-quarter 2021 Cooper Companies earnings conference call. At this time, all participants are in a listen-only mode. After the speakers presentation, there will be a question-and-answer session. [Operator instructions] It is now my pleasure to introduce vice president, investor relations and risk management, Kim Duncan. Kim Duncan Vice President, Investor Relations and Risk Management Good afternoon, and welcome to The Cooper Companies second-quarter 2021 earnings conference call. During today s call, we will discuss the results and guidance included in the earnings release and then use the remaining time for Q&A. Our presenters on today s call are Al White, president and chief executive officer;

Organogenesis Holdings Inc (ORGO) Q1 2021 Earnings Call Transcript

Operator Good afternoon, ladies and gentlemen and welcome to the first-quarter 2021 earnings conference call for Organogenesis Holdings, Inc. [Operator instructions] Please note that this conference call is being recorded and that the recording will be available on the company s website for replay shortly. Before we begin, I would like to remind everyone that our remarks today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including the risks and uncertainties described in the company s filings with the Securities and Exchange Commission, including Item 1A, risk factors of the company s most recent annual and quarterly reports. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made.

Tandem Diabetes Care Inc (TNDM) Q1 2021 Earnings Call Transcript

Operator Good day and thank you for standing by, and welcome to the Q1 Tandem Diabetes Care 2021 Earnings call. [Operator Instructions] I would now like to introduce your host for this conference call, Susan Morrison Susan Morrison Executive Vice President And Chief Administrative Officer Thank you. Good afternoon, everyone, and thanks for joining Tandem s first quarter earnings call for 2021. Today s discussion will include forward-looking statements. These statements reflect management s expectations about future events, product development timelines, and financial performance and operating plans, and speak only as of today s date. There are risks and uncertainties that could cause actual results to differ materially from those anticipated, or projected in our forward-looking statements. A list of factors that could cause actual results to be materially different from those expressed or implied by any of these forward-looking statements is highlighted in our press release i

Glaukos Corp (GKOS) Q1 2021 Earnings Call Transcript

Operator Welcome to Glaukos Corporation s First Quarter 2021 Financial Results Conference Call. A copy of the company s press release issued after the market close today is available at www.glaukos.com or http://www.glaukos.com. [Operator Instructions] This call is being recorded and an archived replay will be available online in the Investor Relations section at www.glaukos.com or http://www.glaukos.com. I will now turn the call over to Chris Lewis, Senior Director of Investor Relations and Corporate Strategy and Development. Chris Lewis Senior Director, Investor Relations, Corporate Strategy and Development Thank you, and good afternoon. Joining me today are Glaukos President and CEO, Tom Burns; CFO, Joe Gilliam; and COO, Chris Calcaterra. Following our prepared remarks, we ll open the call to questions. To ensure ample time and opportunity to address everyone s questions, we request that you limit yourself to one question and one follow-up. If you still have additional que

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.